Biosenta Inc.
ZRO
CNSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -50.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | -100.00% | 0.00% | |||
| SG&A Expenses | 29.43% | -14.22% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.06% | -15.95% | |||
| Operating Income | -33.15% | 15.97% | |||
| Income Before Tax | -6.92% | 8.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.92% | 8.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.92% | 8.47% | |||
| EBIT | -33.15% | 15.97% | |||
| EBITDA | -33.22% | 15.96% | |||
| EPS Basic | -7.03% | 11.11% | |||
| Normalized Basic EPS | -7.50% | 11.11% | |||
| EPS Diluted | -7.03% | 11.11% | |||
| Normalized Diluted EPS | -7.50% | 11.11% | |||
| Average Basic Shares Outstanding | 0.34% | 2.52% | |||
| Average Diluted Shares Outstanding | 0.34% | 2.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||